China Railway Construction Corporation Limited (HKG:1186)
Hong Kong · Delayed Price · Currency is HKD | Market Cap | 112.46B |
| Revenue (ttm) | 1.12T |
| Net Income (ttm) | 20.27B |
| Shares Out | n/a |
| EPS (ttm) | 1.49 |
| PE Ratio | 5.55 |
| Forward PE | 4.85 |
| Dividend | 0.33 (5.78%) |
| Ex-Dividend Date | Jul 14, 2025 |
| Volume | 9,225,000 |
| Average Volume | 16,132,722 |
| Open | 5.61 |
| Previous Close | 5.59 |
| Day's Range | 5.54 - 5.61 |
| 52-Week Range | 4.22 - 7.03 |
| Beta | 0.38 |
| RSI | 48.19 |
| Earnings Date | Aug 30, 2025 |
About Blueprint Medicines
China Railway Construction Corporation Limited, together with its subsidiaries, engages in the construction business in Mainland China and internationally. It operates through five segments: Construction Operations; Planning, Design and Consultancy Operations; Manufacturing Operations; Real Estate Development Operations; and Other Business Operations. The Construction Operations segment engages in the construction of infrastructure, such as railways, highways, rail transits, water conservancy and hydropower, housing construction, municipal engi... [Read more]
Financial Performance
In 2024, HKG:1186's revenue was 1.07 trillion, a decrease of -6.22% compared to the previous year's 1.14 trillion. Earnings were 19.78 billion, a decrease of -16.01%.
Financial StatementsNews
‘It’s not Chinese assistance’: Australia accuses China of taking undue credit for aid projects in the Pacific
Minister Pat Conroy says Chinese ‘branding’ of multilateral development projects to bolster its influence in the region is a consistent frustration Get our breaking news email , free app or daily news...